AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-80
Results: 1-25/80
SEPTICEMIA AND SEPTIC SHOCK IN PEDIATRIC-PATIENTS - 140 CONSECUTIVE CASES ON A PEDIATRIC HEMATOLOGY-ONCOLOGY SERVICE
Authors: ALEDO A HELLER G REN L GARDNER S DUNKEL I MCKAY SW FLOMBAUM C BROWN AE
Citation: A. Aledo et al., SEPTICEMIA AND SEPTIC SHOCK IN PEDIATRIC-PATIENTS - 140 CONSECUTIVE CASES ON A PEDIATRIC HEMATOLOGY-ONCOLOGY SERVICE, Journal of pediatric hematology/oncology, 20(3), 1998, pp. 215-221
BONE-MINERAL DENSITY IN YOUNG-ADULT SURVIVORS OF CHILDHOOD-CANCER
Authors: AISENBERG J KALAITZOGLOU G WHITTAM E HELLER G SCHNEIDER R SKLAR C
Citation: J. Aisenberg et al., BONE-MINERAL DENSITY IN YOUNG-ADULT SURVIVORS OF CHILDHOOD-CANCER, Journal of pediatric hematology/oncology, 20(3), 1998, pp. 241-245
HIGH-RISK OF LEUKEMIA AFTER SHORT-TERM DOSE-INTENSIVE CHEMOTHERAPY INYOUNG-PATIENTS WITH SOLID TUMORS
Authors: KUSHNER BH HELLER G CHEUNG NKV WOLLNER N KRAMER K BAJORIN D POLYAK T MEYERS PA
Citation: Bh. Kushner et al., HIGH-RISK OF LEUKEMIA AFTER SHORT-TERM DOSE-INTENSIVE CHEMOTHERAPY INYOUNG-PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 16(9), 1998, pp. 3016-3020
INTENSIFICATION OF PREOPERATIVE CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA -RESULTS OF THE MEMORIAL SLOAN-KETTERING (T12) PROTOCOL
Authors: MEYERS PA GORLICK R HELLER G CASPER E LANE J HUVOS AG HEALEY JH
Citation: Pa. Meyers et al., INTENSIFICATION OF PREOPERATIVE CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA -RESULTS OF THE MEMORIAL SLOAN-KETTERING (T12) PROTOCOL, Journal of clinical oncology, 16(7), 1998, pp. 2452-2458
HIGH-DOSE INDUCTION CHEMORADIOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY IN RHABDOMYOSARCOMA, EXTRAOSSEOUS EWINGS-SARCOMA, AND UNDIFFERENTIATED SARCOMA
Authors: BOULAD F KERNAN NA LAQUAGLIA MP HELLER G LINDSLEY KL ROSENFIELD NS ABRAMSON SJ GERALD WL SMALL TN GILLIO AP GULATI SC OREILLY RJ GHAVIMI F
Citation: F. Boulad et al., HIGH-DOSE INDUCTION CHEMORADIOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY IN RHABDOMYOSARCOMA, EXTRAOSSEOUS EWINGS-SARCOMA, AND UNDIFFERENTIATED SARCOMA, Journal of clinical oncology, 16(5), 1998, pp. 1697-1706
INTENSIVE CHEMOTHERAPY AND BONE-MARROW RESCUE FOR YOUNG-CHILDREN WITHNEWLY-DIAGNOSED MALIGNANT BRAIN-TUMORS
Authors: MASON WP GROVAS A HALPERN S DUNKEL IJ GARVIN J HELLER G ROSENBLUM M GARDNER S LYDEN D SANDS S PUCCETTI D LINDSLEY K MERCHANT TE OMALLEY B BAYER L PETRICCIONE MM ALLEN J FINLAY JL
Citation: Wp. Mason et al., INTENSIVE CHEMOTHERAPY AND BONE-MARROW RESCUE FOR YOUNG-CHILDREN WITHNEWLY-DIAGNOSED MALIGNANT BRAIN-TUMORS, Journal of clinical oncology, 16(1), 1998, pp. 210-221
HLA-DQBI DISPARITY BETWEEN PATIENTS AND UNRELATED MARROW DONORS (URD)MATCHED FOR HLA-A, HLA-B, AND HLA-DRB1 BY DNA TYPING
Authors: PRASAD VK KERNAN NA HELLER G OREILLY RJ YANG SY
Citation: Vk. Prasad et al., HLA-DQBI DISPARITY BETWEEN PATIENTS AND UNRELATED MARROW DONORS (URD)MATCHED FOR HLA-A, HLA-B, AND HLA-DRB1 BY DNA TYPING, Experimental hematology, 26(8), 1998, pp. 33-33
HLA-C DISPARIN BETWEEN PATIENTS AND UNRELATED DONORS (URD) MATCHED FOR HLA-A, HLA-B, AND HLA-DRBI ALLELES BY DNA TYPING
Authors: PRASAD VK KERNAN NA HELLER G OREILLY RJ YANG SY
Citation: Vk. Prasad et al., HLA-C DISPARIN BETWEEN PATIENTS AND UNRELATED DONORS (URD) MATCHED FOR HLA-A, HLA-B, AND HLA-DRBI ALLELES BY DNA TYPING, Experimental hematology, 26(8), 1998, pp. 34-34
SPINAL GANGLIOGLIOMA
Authors: JANSS A HELLER G DANGIO GJD EVANS AE SUTTON L RORKE L DORMANS JP GOLDWEIN J HIMELSTEIN B
Citation: A. Janss et al., SPINAL GANGLIOGLIOMA, Medical and pediatric oncology, 31(2), 1998, pp. 116-122
THE HISTOLOGICAL RESPONSE TO CHEMOTHERAPY AS A PREDICTOR OF THE ONCOLOGICAL OUTCOME OF OPERATIVE TREATMENT OF EWING SARCOMA
Authors: WUNDER JS PAULIAN G HUVOS AG HELLER G MEYERS PA HEALEY JH
Citation: Js. Wunder et al., THE HISTOLOGICAL RESPONSE TO CHEMOTHERAPY AS A PREDICTOR OF THE ONCOLOGICAL OUTCOME OF OPERATIVE TREATMENT OF EWING SARCOMA, Journal of bone and joint surgery. American volume, 80A(7), 1998, pp. 1020-1033
T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE
Authors: PAPADOPOULOS EB CARABASI MH CASTROMALASPINA H CHILDS BH MACKINNON S BOULAD F GILLIO AP KERNAN NA SMALL TN SZABOLCS P TAYLOR J YAHALOM J COLLINS NH BLEAU SA BLACK PM HELLER G OREILLY RJ YOUNG JW
Citation: Eb. Papadopoulos et al., T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE, Blood, 91(3), 1998, pp. 1083-1090
DIFFERENTIATED THYROID-CANCER - DETERMINANTS OF DISEASE PROGRESSION IN PATIENTS LESS-THAN-21 YEARS OF AGE AT DIAGNOSIS - A REPORT FROM THE SURGICAL DISCIPLINE COMMITTEE OF THE CHILDRENS-CANCER-GROUP
Authors: NEWMAN KD BLACK T HELLER G AZIZKHAN RG HOLCOMB GW SKLAR C VLAMIS V HAASE GM LAQUAGLIA MP
Citation: Kd. Newman et al., DIFFERENTIATED THYROID-CANCER - DETERMINANTS OF DISEASE PROGRESSION IN PATIENTS LESS-THAN-21 YEARS OF AGE AT DIAGNOSIS - A REPORT FROM THE SURGICAL DISCIPLINE COMMITTEE OF THE CHILDRENS-CANCER-GROUP, Annals of surgery, 227(4), 1998, pp. 533-541
BIS[MU-NITRIDO-BIS(DIORGANYLPHOSPHINATO-O ITRIDO-BIS(DIORGANYLPHOSPHINATO-O,O')]-ELEMENT(1+) CATIONS() AND TRIS[MU)
Authors: JIRJAHN B HILDEBRANDT H HELLER G
Citation: B. Jirjahn et al., BIS[MU-NITRIDO-BIS(DIORGANYLPHOSPHINATO-O ITRIDO-BIS(DIORGANYLPHOSPHINATO-O,O')]-ELEMENT(1+) CATIONS() AND TRIS[MU), Zeitschrift fur Naturforschung. B, A journal of chemical sciences, 52(1), 1997, pp. 95-101
DOES NUCLEAR TESTING YIELD INCREMENTAL INFORMATION FOR THE PREDICTIONOF DEATH IN PATIENTS WITH NORMAL REST EGG - A MULTICENTER STUDY OF 5554 PATIENTS WITH STABLE ANGINA
Authors: HACHAMOVITCH R SHAW LJ KESLER K BORGESNETO S HELLER G TRAVIN M MILLER DD BERMAN DS
Citation: R. Hachamovitch et al., DOES NUCLEAR TESTING YIELD INCREMENTAL INFORMATION FOR THE PREDICTIONOF DEATH IN PATIENTS WITH NORMAL REST EGG - A MULTICENTER STUDY OF 5554 PATIENTS WITH STABLE ANGINA, Journal of the American College of Cardiology, 29(2), 1997, pp. 94925-94925
DETECTION OF METASTATIC NEUROBLASTOMA IN BONE-MARROW - WHEN IS ROUTINE MARROW HISTOLOGY INSENSITIVE
Authors: CHEUNG NKV HELLER G KUSHNER BH LIU CY CHEUNG IY
Citation: Nkv. Cheung et al., DETECTION OF METASTATIC NEUROBLASTOMA IN BONE-MARROW - WHEN IS ROUTINE MARROW HISTOLOGY INSENSITIVE, Journal of clinical oncology, 15(8), 1997, pp. 2807-2817
ALL-TRANS-RETINOIC ACID SIGNIFICANTLY INCREASES 5-YEAR SURVIVAL IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA - LONG-TERM FOLLOW-UP OF THE NEW-YORK STUDY
Authors: SOIGNET S FLEISCHAUER A POLYAK T HELLER G WARRELL RP
Citation: S. Soignet et al., ALL-TRANS-RETINOIC ACID SIGNIFICANTLY INCREASES 5-YEAR SURVIVAL IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA - LONG-TERM FOLLOW-UP OF THE NEW-YORK STUDY, Cancer chemotherapy and pharmacology, 40, 1997, pp. 25-29
RISK OF EXTRAMEDULLARY RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA WITH LEUKEMIA-CUTIS
Authors: MICHEL G BOULAD F SMALL TN BLACK P HELLER G CASTROMALASPINA H CHILDS BH GILLIO AP PAPADOPOULOS EB YOUNG JW KERNAN NA OREILLY RJ
Citation: G. Michel et al., RISK OF EXTRAMEDULLARY RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA WITH LEUKEMIA-CUTIS, Bone marrow transplantation, 20(2), 1997, pp. 107-112
INCREMENTAL RISK STRATIFICATION WITH CLINICAL HISTORY, EXERCISE TREADMILL, AND EXERCISE MYOCARDIAL PERFUSION
Authors: HACHAMOVITCH R SHAW LJ KESLER K BORGESNETO S HELLER G TRAVIN M MILLER DD BERMAN DS
Citation: R. Hachamovitch et al., INCREMENTAL RISK STRATIFICATION WITH CLINICAL HISTORY, EXERCISE TREADMILL, AND EXERCISE MYOCARDIAL PERFUSION, The Journal of nuclear medicine, 38(5), 1997, pp. 140-140
TREATMENT OF STANDARD RISK MEDULLOBLASTOMA WITH CRANIOSPINAL IRRADIATION, CARBOPLATIN, AND VINCRISTINE
Authors: BERGMAN I JAKACKI RI HELLER G FINLAY J
Citation: I. Bergman et al., TREATMENT OF STANDARD RISK MEDULLOBLASTOMA WITH CRANIOSPINAL IRRADIATION, CARBOPLATIN, AND VINCRISTINE, Medical and pediatric oncology, 29(6), 1997, pp. 563-567
LATE RESULTS USING THE CHILDS-PHILLIPS ME THOD OF TRANSMESENTERIC SMALL-BOWEL PLICATION
Authors: SCLABAS G HELLER G LUDIN A ODSTRCILIK E AMMANN J
Citation: G. Sclabas et al., LATE RESULTS USING THE CHILDS-PHILLIPS ME THOD OF TRANSMESENTERIC SMALL-BOWEL PLICATION, Chirurg, 68(7), 1997, pp. 693-699
LINKAGE DISEQUILIBRIUM (LD) BETWEEN HLA-B AND HLA-C ALLELES - PROBABILITY OF HLA-C IDENTITY BETWEEN PATIENTS AND UNRELATED DONORS WITH IDENTICAL HLA-B ALLELES
Authors: PRASAD VK HELLER G YANG SY
Citation: Vk. Prasad et al., LINKAGE DISEQUILIBRIUM (LD) BETWEEN HLA-B AND HLA-C ALLELES - PROBABILITY OF HLA-C IDENTITY BETWEEN PATIENTS AND UNRELATED DONORS WITH IDENTICAL HLA-B ALLELES, Blood, 90(10), 1997, pp. 440-440
DNA TYPING FOR HLA-A AND HLA-B IDENTIFIES DISPARITIES BETWEEN PATIENTS AND UNRELATED DONORS MATCHED BY HLA-A AND HLA-B SEROLOGY AND DRB1
Authors: PRASAD VK KERNAN NA HELLER G OREILLY RJ YANG SY
Citation: Vk. Prasad et al., DNA TYPING FOR HLA-A AND HLA-B IDENTIFIES DISPARITIES BETWEEN PATIENTS AND UNRELATED DONORS MATCHED BY HLA-A AND HLA-B SEROLOGY AND DRB1, Blood, 90(10), 1997, pp. 2503-2503
HLA-C DISPARITY BETWEEN PATIENTS AND UNRELATED DONORS MATCHED FOR HLA-A, HLA-B AND HLA-DRB1 ALLELES BY DNA TYPING
Authors: PRASAD VK KERNAN NA HELLER G OREILLY RJ YANG SY
Citation: Vk. Prasad et al., HLA-C DISPARITY BETWEEN PATIENTS AND UNRELATED DONORS MATCHED FOR HLA-A, HLA-B AND HLA-DRB1 ALLELES BY DNA TYPING, Blood, 90(10), 1997, pp. 2504-2504
PEDIATRIC RHABDOMYOSARCOMA OF THE HEAD AND NECK
Authors: KRAUS DH SAENZ NC GOLLAMUDI S HELLER G MOUSTAKIS M GARDINER S GERALD WL GHAVIMI F LAQUAGLIA MP
Citation: Dh. Kraus et al., PEDIATRIC RHABDOMYOSARCOMA OF THE HEAD AND NECK, The American journal of surgery, 174(5), 1997, pp. 556-560
GROWTH AND FINAL HEIGHT AFTER TREATMENT FOR CHILDHOOD HODGKIN DISEASE
Authors: PAPADAKIS V TAN C HELLER G SKLAR C
Citation: V. Papadakis et al., GROWTH AND FINAL HEIGHT AFTER TREATMENT FOR CHILDHOOD HODGKIN DISEASE, Journal of pediatric hematology/oncology, 18(3), 1996, pp. 272-276
Risultati: 1-25 | 26-50 | 51-75 | 76-80